Combination treatment for metastatic melanoma results in longer overall survival

Among patients with metastatic melanoma, treatment with a combination of the drugs sargramostim plus ipilimumab, compared with ipilimumab alone, resulted in longer overall survival and lower toxicity, but no difference in progression-free survival, according to a study.

Read the whole article on Science Daily

More from Science Daily